Arrhythmogenic Substrate in Primary Cardiomyopathies and/or Channellopathies
Arrhythmogenic Substrate Assessment in Patients With Primary Cardiomyopathies and/or Channellopaties With and Without History of Brugada Syndrome: A Prospective Follow-up Study
Sponsor: IRCCS Policlinico S. Donato
Listed as NCT03304847, this NA trial focuses on Cardiomyopathy and remains ongoing. Sponsored by IRCCS Policlinico S. Donato, it has been updated 13 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
13 versions recorded-
Oct 2025 — Present [monthly]
Unknown NA
Status: Recruiting → Unknown
-
Sep 2024 — Oct 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Nov 2023 — Jul 2024 [monthly]
Recruiting NA
-
Oct 2023 — Nov 2023 [monthly]
Recruiting NA
▶ Show 8 earlier versions
-
May 2021 — Oct 2023 [monthly]
Recruiting NA
-
Jan 2021 — May 2021 [monthly]
Recruiting NA
-
Dec 2020 — Jan 2021 [monthly]
Recruiting NA
-
Apr 2020 — Dec 2020 [monthly]
Recruiting NA
-
Mar 2019 — Apr 2020 [monthly]
Recruiting NA
-
Jun 2018 — Mar 2019 [monthly]
Recruiting NA
-
Nov 2017 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Oct 2017 — Nov 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- IRCCS Policlinico S. Donato
For direct contact, visit the study record on ClinicalTrials.gov .